A made-in-B.C. innovation is playing a critical role in the Pfizer-BioNTech COVID-19 vaccine rolling out across the globe. Lipid nanoparticle technology — or LNP — developed by Vancouver’s Acuitas Therapeutics is one of the key factors allowing the vaccine to work. Acuitas co-founder Pieter Cullis joins BIV Today to break it down. Tyler Orton hosts.

<p>A made-in-B.C. innovation is playing a critical role in the Pfizer-BioNTech COVID-19 vaccine rolling out across the globe. Lipid nanoparticle technology &mdash; or LNP &mdash; developed by Vancouver&rsquo;s Acuitas Therapeutics is one of the key factors allowing the vaccine to work. Acuitas co-founder Pieter Cullis joins BIV Today to break it down. Tyler Orton hosts.</p>

British Columbia's only daily news show focused on business, brought to you by Business in Vancouver newspaper and biv.com. Join hosts editor-in-chief Kirk LaPointe as well as reporters Tyler Orton and Hayley Woodin as they interview Canada's business and political leaders about the pressing issues facing British Columbian businesses and industries today. Join them as they discuss real estate, technology, the resource industries and local and provincial politics.

Advertisement